FDA Panel Recommends Rejection Of Eli Lilly Drug Gemzar To Treat Ovarian Cancer

... An FDA panel on Monday voted 9-2 to recommend the agency reject an application by Eli Lilly to market the drug Gemzar, in combination with FDA-approved carboplatin, as a treatment for advanced ovarian cancer, Dow Jones/Wall Street Journal reports. FDA in 1996 approved Gemzar, which is considered a chemotherapy drug, to treat pancreatic cancer, and since then it has been approved as a treatment for lung and breast cancers... click link for more info. ...